Simbar, Masoumeh
Kiani, Zahra
Shaterian, Negin
Bidgoli, Mohammadamin Jandaghian
Shaterian, Negar
Bayani, Ghasem
Rashidi, Farzaneh
Nasiri, Maliheh
Article History
Received: 14 September 2024
Accepted: 11 October 2024
First Online: 21 October 2024
Declarations
:
: The study was approved by the ethics committee of Shahid Beheshti University of Medical Sciences with the ethics code IR.SBMU.PHARMACY.REC.1400.287. All methods were carried out under relevant guidelines and regulations. Participation in the study was fully voluntary and contingent on consent and all methods were carried out under relevant guidelines and regulations. To maintain the confidentiality of participants’ data, the questionnaires were completed anonymously with no identification number. At the beginning of each questionnaire, the electronically informed consent option to participate in the research was placed and all participants provided electronically informed consent to include in the study. The participants could withdraw from the study at any time without consequences. We tried to provide women with information on support services such as domestic violence hotlines and counseling services after the questionnaire. participants have the opportunity to ask questions or request further clarification about the study.
: “Not applicable” in this section.
: The authors declare no competing interests.